Advertisement
Skip to Content

Athersys Inc ATHX Stock Quote

| Rating as of

NASDAQ: ATHX

Last close prices updated as of Jan 31, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 1.51
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range 1.47  –  1.61
  • Year Range 0.50  –  33.25
  • Market Cap 25.9855 Mil
  • Volume / Avg 180,325.0 /  761,374.5
  • Price / Sales 58.52
  • Price / Book 219.57
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis ATHX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ATHX

Company Profile ATHX

Business Description

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Contact
3201 Carnegie Avenue
Cleveland, OH, 44115-2634
Industry Biotechnology
Employees 104

FAQs for Athersys Inc Stock

No. ATHX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ATHX’s market cap is 25.99 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ATHX’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ATHX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ATHX’s historical performance against its industry peers and the overall market.